Target intelligence / Profile preview

CUGBP Elav-like family member 5 (CELF5)

Target
CELF5
Molecular classification
RNA-binding protein, Splicing regulator, Other
01

Overview

CUGBP Elav-like family member 5 (CELF5) is a member of the CELF/BRUNOL family of RNA-binding proteins, characterized by multiple RNA recognition motif (RRM) domains. CELF5 regulates pre-mRNA alternative splicing, contributing to exon inclusion or exclusion in a tissue- and developmentally-specific manner. It is especially active in processing muscle-specific and neural pre-mRNAs, and its function is implicated in coordinated post-transcriptional gene regulation during development and in certain neurological disorders. CELF5 is not a classical receptor, enzyme, or transporter but plays a critical role in RNA metabolism and alternative splicing, placing it outside standard drug-target classes[1][5][6][7]. **Note:** - CELF5 is not currently considered a direct therapeutic target for drugs, and there are no known drugs or drug mechanisms or biomarker/safety information directly associated with this protein. - Its relevance is in fundamental RNA biology and the etiology of certain neurodevelopmental disorders, rather than in targeted pharmacological intervention.

Other names
BRUNOL5CELF-5Bruno-like protein 5CUG-BP- and ETR-3-like factor 5RNA-binding protein BRUNOL-5bruno-like 5 RNA binding protein
02

Biological functions

Regulation of pre-mRNA alternative splicingRNA bindingRegulation of mRNA editing and translation
03

Disease associations

Developmental coordination disorderSpinocerebellar ataxia with axonal neuropathyOther (not a major cancer, cardiovascular, or inflammation target)

Beyond the preview

Go deeper on CUGBP Elav-like family member 5 (CELF5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CUGBP Elav-like family member 5 (CELF5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call